Royal Canin Japan LLC (Headquarters: Minato-ku, Tokyo; President: Shinichi Kusakabe; hereinafter referred to as Royal Canin), a company that realizes the health of dogs and cats based on nutrition, offering premium pet food and therapeutic diets, will renew its "GlycoBalance" series for cats and dogs and launch new products. Obesity is one of the significant factors affecting the health of cats. Many cats with diabetes are also obese, making nutritional management through diet extremely important. The new "GlycoBalance Advanced" for cats (dry and wet), launched this time, is a therapeutic diet that addresses both weight loss and blood glucose maintenance in the management of cats with diabetes accompanied by obesity. Based on new clinical data, it supports nutritional management according to veterinary treatment plans and appropriate diabetes management by pet owners by enabling proper nutritional management from the early stages of diagnosis. Furthermore, we are launching "GlycoBalance Small Breed" for dogs, targeting small dogs, which are numerous in Japan. "GlycoBalance Small Breed" for dogs is nutritionally designed to provide appropriate nutritional management for diabetes in small dogs, as well as to maintain the health of their digestive system, teeth, and lower urinary tract. The kibble size and shape are designed to be easy for small dogs to eat, supporting the health of more dogs. These products are VDEC-registered therapeutic diets intended for nutritional management of pets with specific diseases or health conditions, and can be purchased at animal hospitals nationwide, Royal Canin's official and certified online stores, and certified physical stores, under the diagnosis and guidance of a veterinarian. *1 Launched for animal hospitals by Kyowa Pharmaceutical Co., Ltd. Available at Royal Canin's official and certified online stores and certified physical stores. *2 VDEC (Veterinary Diet Evaluation Center) is a non-profit third-party organization that prom